Philosophy of Care
Dr. Afify's philosophy is that patient care comes first under all circumstances, and never to delay any work.
Dr. Afify's subspecialty is cytopathology, including fine-needle aspiration cytology, body fluids and Pap tests. He is a recognized expert in performing and evaluating fine-needle aspiration biopsies. Other areas of expertise include gynecologic and endocrine pathology.
Dr. Afify has research interests in hyaluronan and its receptor, CD44. He is researching the role of CD44 on cancer, including its effects on cell migration, invasion and proliferation. Recently, his lab is developing immunoliposomes that will target specific cancer cells.
M.D., Alexandria University and School of Medicine, Alexandria, 1981
Internship: Woodhull Medical and Mental Health Center, New York City NY 1991-1992
Anatomic Pathology & Clinical Pathology, Brown University School of Medicine, Providence RI 1992-1996
Cytopathology, Washington University School of Medicine, St. Louis MO 1997-1998
Oncologic Surgical Pathology, Roswell Park Cancer Institute, Buffalo NY 1996-1997
American Board of Pathology, Anatomic and Clinical Pathology, 1997
American Board of Pathology, Cytopathology, 1998
American Society of Cytopathology
College of American Pathologists
United States and Canadian Academy of Pathology
Honors and Awards
Best graduating resident of the year, 1996
Select Recent Publications
Afify AM, Tate S, Durbin-Johnson B, Rocke DM, Konia T. Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors. Int J Biol Markers. 2011 Jan-Mar;26(1):50-7.
Devaraj S, Tobias P, Kasinath BS, Ramsamooj R, Afify A, Jialal I. Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy. Arterioscler Thromb Vasc Biol. 2011 Aug;31(8):1796-804. Epub 2011 May 26
Alaa Afify and Lydia Howell. Cervical cancer screening, effective clinician and laboratory partnership. J of female patient, 2010 35(8):27-29.
Afify A, Purnell P, Nguyen L. Role ofCD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion. Exp Mol Pathol, 86(2): 95-100. 2009
Afify A, Yu C, Hejazi N, Howell L. The Diagnostic Utility of Cell Blocks Prepared From Residual SurePath Pap Material for Detection of Human Papilloma Virus. Appl Immunohistochem Mol Morphol, 95-100. 2009
Howell LP, Wilton M, Bishop J, Afify A. Living with uncertainty: Equivocal Pap test results and the evolution of ASC terminology. Diagn Cytopathol. 2009 Oct 23. [Epub ahead ofprint] PMID: 19856423
Singh U, Dasu MR, Yancey PG, Afify A, Devaraj S, Jialal 1.Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats. J Lipid Res, 49(5): 1015-23. 2008
Afify A, McNiel MA, Braggin J, Bailey H, Paulino AF. Expression of CD44s, CD44v6, and hyaluronan across the spectrum of normal-hyperplasia-carcinoma in breast. Appl Immunohistochem Mol Morphol, 16(2): 121-7. 2008
Afify AM, Lin-Chang L, Howell L. Correlation of Cytologic Examination with ELISA Assays for Hyaluronan and Soluble CD44v6 Levels in Evaluation of Effusions. Diagnostic cytopathology, 35: 105-110. 2007
Afify AM, Pang L, Howell L. Diagnostic Utility of CD44 standard, CD44v6, and CD44v3-10 Expression in Adenocarcinomas Presenting in Serous Fluids. Applied Immunohistochemistry & Molecular Morphology, 15(4): 446-50. 2007